Britain's Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday said it approved gepotidacin, also known as Blujepa, a new kind of oral antibiotic pill to treat uncomplicated urinary ...

A new antibiotic to treat urinary tract infections (UTIs) for the first time in almost three decades has been given the green ...

CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted ...

The UK's medicines regulator has approved GSK's Blujepa for treating UTIs in females aged 12 and older. Blujepa's active ...

Britain's medicines regulator said on Thursday it approved GSK's Blujepa, an antibiotic pill, to treat uncomplicated urinary tract infections (UTIs) in females aged 12 and older.

As with any medicine, the MHRA will keep the safety of gepotidacin under close review. The Medicines and Healthcare products ...

The MHRA aims to refine a 2021 policy that exempts medical devices made and used by health institutions from certain requirements.

Parents and caregivers in the United Kingdom have been advised to immediately stop giving children Nutrition Ignition Kids ...

On July 8, ImmunityBio, Inc. (NASDAQ:IBRX) announced that the UK’s Medicines and Healthcare products Regulatory Agency has approved ANKTIVA with Bacillus Calmette-Guérin for treating certain ...

HealthTech firm Sanome has gained regulatory approval for its AI warning system which predicts and prevents ...

The wholly-owned step-down subsidiary of Aurobindo Pharma, CuraTeQ Biologics s.r.o., has secured a marketing authorisation ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has ruled Vertex broke the U.K. drug regulations with a LinkedIn post, prompting the big biotech to review its social media policies.